Vera Hirsh, MD

Primary Axis: 
Cancer
Email: 
Email contact form
Research Focus: 

Research is focused on the treatment of lung cancer; clinical, phase I, II, and III trials.Lung cancer, treatments, clinical trials

Keywords: 
Lung cancer, treatments, clinical trials
Location: 
Royal Victoria Hospital
Publications:
Hirsh V, Whittom R, Desjardins P, Laberge F, Latreille J, Samson B, Langleben A. Docetaxel and gemcitabine administered on days one and eight for metastatic non-small cell lung carcinoma (NSCLC): A phase II multicenter trial. Accepted for publication in Lung Cancer (IASLC) Journal – February 2004.
Hirsh V, Whittom R, Ofiara L, Desjardins P, Ayoub J, Charpentier D, Small D, Pintos J, Langleben A. Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): A dose-optimizing phase II trial. Cancer 2003; 97: 2242-2247.
Hirsh V, Langleben A, Ayoub J, Cormier Y, Pintos J, Iglesias JL. Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic non-small cell lung carcinoma (NSCLC): A phase II multicenter trial. Cancer 2001; 92: 830-835.